Skip to main content

Table 1 Linear association between single urinary VOC metabolites and blood lipid parameters

From: The association between exposure to volatile organic compounds and serum lipids in the US adult population

VOCs

TC

TG

HDL

LDL

β (95% CI)

P

β (95% CI)

P

β (95% CI)

P

β (95% CI)

P

2MHA

2.15 (0, 4.29)

0.06

1.69 (-1.93, 5.3)

0.37

-0.35 (-1.24, 0.54)

0.45

2.17 (0.47, 3.86)

0.02

3MHA + 4MHA

1.57 (-0.74, 3.87)

0.19

2.77 (-0.86, 6.4)

0.15

-0.43 (-1.3, 0.44)

0.34

1.46 (-0.38, 3.29)

0.13

AAMA

-0.63 (-4.46, 3.2)

0.75

-0.09 (-6.82, 6.64)

0.98

1.28 (0.21, 2.36)

0.03

-1.87 (-5.33, 1.58)

0.3

AMCC

3.12 (-0.15, 6.4)

0.07

7.58 (0.43, 14.73)

0.05

-0.89 (-2.31, 0.54)

0.23

2.51 (-0.57, 5.59)

0.12

ATCA

3.16 (0.11, 6.21)

0.05

-1.05 (-6.27, 4.17)

0.7

0.65 (-0.47, 1.77)

0.27

2.72 (-0.03, 5.47)

0.06

BMA

0.74 (-2.55, 4.02)

0.66

4.81 (0.24, 9.38)

0.05

1.05 (-0.05, 2.16)

0.07

-1.28 (-3.99, 1.43)

0.36

BPMA

1.16 (-1.21, 3.53)

0.34

-1.44 (-4.43, 1.54)

0.35

-0.27 (-0.88, 0.34)

0.4

1.72 (-0.31, 3.76)

0.11

CEMA

2.77 (-1.04, 6.58)

0.17

9.64 (4.57, 14.7)

< 0.01*

-1.19 (-2.42, 0.03)

0.07

2.05 (-1.56, 5.67)

0.27

CYMA

1.41 (-0.26, 3.08)

0.11

4.82 (2.18, 7.46)

< 0.01*

-0.39 (-0.99, 0.2)

0.21

0.85 (-0.71, 2.4)

0.3

DHBMA

0.11 (-5.87, 6.1)

0.97

4.83 (-5.97, 15.64)

0.39

2.59 (0.19, 4.99)

0.04

-3.44 (-9.11, 2.23)

0.24

2HPMA

-0.23 (-3.47, 3.01)

0.89

-1.7 (-6.62, 3.22)

0.5

-0.1 (-1.03, 0.83)

0.83

0.2 (-2.44, 2.84)

0.88

3HPMA

2.14 (-1.93, 6.22)

0.31

8.3 (2.98, 13.63)

< 0.01*

-0.46 (-1.59, 0.67)

0.43

0.97 (-2.78, 4.72)

0.62

MA

7.01 (2.78, 11.24)

< 0.01*

8.81 (0.5, 17.13)

0.05

2.04 (0.16, 3.92)

0.04

3.22 (-0.8, 7.24)

0.13

MHBMA3

-0.12 (-3.08, 2.84)

0.94

6.71 (1.25, 12.16)

0.02

-1.18 (-2.27, -0.09)

0.04

-0.27 (-2.78, 2.24)

0.83

PGA

2.28 (-2.7, 7.26)

0.38

6.58 (-1.05, 14.22)

0.1

0.26 (-1.26, 1.78)

0.74

0.71 (-4.28, 5.71)

0.78

HPMMA

0.69 (-2.64, 4.03)

0.69

10.78 (4.54, 17.01)

< 0.01*

-0.57 (-2, 0.85)

0.44

-0.87 (-3.77, 2.02)

0.56

  1. *, adjusted P < 0.05: the effective number of tests (Meff)
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X